Launch of PharMADNESS – an online game that exposes the profit-driven nature of drug development.
On the 10th October STOPAIDS Missing Medicines campaign is launching PharMADNESS - an online, interactive game that puts you in the seat of a Big Pharma exec and exposes the profit-driven nature of our system for developing medicines. The event will include a panel...
read more
Missing Medicine campaign commends the recommendations of the UN High Level Panel on Access to Medicines and the call from panel members to go further
Three months after the original deadline, the UN High Level Panel on Access to Medicines (HLP) FINAL REPORT is finally out. In December 2015 Ban Ki Moon set up the HLP with the mandate to solve the policy incoherence between human rights, trade, Intellectual Property...
read more
AstraZeneca: refusing people in Africa access to cancer treatment?
'There's no point giving free cancer drugs to Africa' a shocking headline, but not surprising when you realise it is propagated by the CEO of a BIG PHARMA company. The BBC article published last week outlined how Pascal Soriot, CEO of AstraZeneca doesn’t see tackling...
read more
Campaign wins! Needs-based R&D, plans for sustainable funding and space for future talks around an R&D agreement: the WHA resolution on R&D for health is better than expected!
For the past 8 months the Missing Medicines campaign has been calling on the UK government to support the establishment of a global R&D agreement to ensure we produce the medicines we all need at prices we can afford. Over 6,000 people have taken action and on...
read more
Celebrating 6,000 people taking action as part of the Missing Medicines campaign
Today Missing Medicines campaigners met up in Westminster to take some snaps to celebrate the 6,000 people who have take action as part of the Missing Medicines campaign in the last 8 months! Thanks to each person for their energy and dedication to achieving universal...
read more
Will we get the R&D reforms we want at this week’s World Health Assembly?
This week is the World Health Assembly where a resolution on Research and Development will be drafted and agreed upon by member states. This is a moment the Missing Medicines campaign has been working towards for quite some time with over 6,000 people taking action...
read more
STOPAIDS, KEI and HAI statement at the CEWG open-ended meeting on R&D 2016
From May 2nd-4th the World Health Organisation's Consultative Expert Working Group on R&D (CEWG) have held an open-ended meeting to discuss reforms to our current R&D model and address market failures that lead to diseases areas being ignored and medicines...
read more
Civil society urges Member States to support the Dutch EU Presidency’s vision on access to affordable medicines
Missing Medicines campaign urges Member States to support the Dutch EU Presidency’s vision on access to affordable medicines Call for backing comes as Health Ministers meet in Amsterdam today. Missing Medicine's campaign strongly support the Dutch European Union (EU)...
read more
Youth Stop AIDS vs MARTIN SHKRELI
Youth Stop AIDS challenging the system and raising awareness about the UN High Level Panel on Access to...
read more
AIDS activists go bare to target austerity
AIDS activists go bare to target austerity...
read more
The Young People Fighting AIDS and BIG PHARMA
The Young People Fighting AIDS and BIG...
read more
High-Level UN Initiative On Global Public Health Gap Holds Landmark Hearing
High-Level UN Initiative On Global Public Health Gap Holds Landmark...
read moreGSK expand access to medicines but much more needs to be done
GlaxoSmithKline (GSK) recently announced in a press release that it would be expanding its graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries. GSK have said that they won’t file patents in Least...
read moreMe Too Drugs
Fojo T et al. “Unintended consequences of expensive cancer therapeutics – the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity” JAMA Otolaryngology Head and Neck Surgery (2014). Prescrire (2014); 34 (364):132-136 ‘New drugs...
read moreGilead admit that high prices aren’t to cover R&D
ACCESS DENIED: Report of the Inquiry of the All Party Parliamentary Group on HIV and AIDS into access to medicines in the developing world December 2014 http://impactaids.co.uk/wp-content/uploads/ACCESS-DENIED-APPG-Report-1.12.14.pdf...
read moreThe CEWG report
Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (2012) “Research and Development to meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”...
read moreOne in four HIV/AIDS treatments would not exists without university research
Sampat, B. N. (2009). Academic patents and access to medicines in developing countries. American journal of public health, 99(1), 9-17.
read moreBetween 1/4 and 1/3 of new drugs originate in a university lab
Kneller, R. (2010). The importance of new companies for drug discovery: origins of a decade of new drugs. Nature Reviews Drug Discovery, 9(11), 867-882.
read more